These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 27373855)

  • 21. Severe asthma: what is new in the new millennium.
    Ntontsi P; Samitas K; Zervas E; Gaga M
    Curr Opin Allergy Clin Immunol; 2020 Apr; 20(2):202-207. PubMed ID: 32004177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the interleukin pathway in the treatment of asthma.
    Chung KF
    Lancet; 2015 Sep; 386(9998):1086-96. PubMed ID: 26383000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal Antibodies for the Management of Severe Asthma.
    Rubinsztajn R; Chazan R
    Adv Exp Med Biol; 2016; 935():35-42. PubMed ID: 27334730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of T2 inflammation biomarkers in severe asthma.
    Parulekar AD; Diamant Z; Hanania NA
    Curr Opin Pulm Med; 2016 Jan; 22(1):59-68. PubMed ID: 26574724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic effects of anti-B7-H3 antibody in an ovalbumin-induced mouse asthma model.
    Chen ZR; Zhang GB; Wang YQ; Yan YD; Zhou WF; Zhu C; Chen Y; Wang J; Ji W
    Ann Allergy Asthma Immunol; 2013 Oct; 111(4):276-81. PubMed ID: 24054363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypes/endotypes-driven treatment in asthma.
    Braido F; Tiotiu A; Kowal K; Mihaicuta S; Novakova P; Oguzulgen IK
    Curr Opin Allergy Clin Immunol; 2018 Jun; 18(3):184-189. PubMed ID: 29601354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of monoclonal antibodies for asthma treatment.
    Bagnasco D; Heffler E; Testino E; Passalacqua G; Canonica GW
    Expert Opin Drug Metab Toxicol; 2019 Feb; 15(2):113-120. PubMed ID: 30632416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Narrative review: the role of Th2 immune pathway modulation in the treatment of severe asthma and its phenotypes.
    Levine SJ; Wenzel SE
    Ann Intern Med; 2010 Feb; 152(4):232-7. PubMed ID: 20157138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agents against cytokine synthesis or receptors.
    Yamagata T; Ichinose M
    Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging Biologics in Severe Asthma.
    Pavord ID; Hilvering B; Shrimanker R
    Immunol Allergy Clin North Am; 2016 Aug; 36(3):609-23. PubMed ID: 27401629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging interleukin receptor antagonists for the treatment of asthma.
    Al Efraij K; FitzGerald JM
    Expert Opin Emerg Drugs; 2017 Sep; 22(3):275-283. PubMed ID: 28832218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Th2 cytokine antagonists: potential treatments for severe asthma.
    Hansbro PM; Scott GV; Essilfie AT; Kim RY; Starkey MR; Nguyen DH; Allen PD; Kaiko GE; Yang M; Horvat JC; Foster PS
    Expert Opin Investig Drugs; 2013 Jan; 22(1):49-69. PubMed ID: 23126660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 18β-Glycyrrhetinic acid, the major bioactive component of Glycyrrhizae Radix, attenuates airway inflammation by modulating Th2 cytokines, GATA-3, STAT6, and Foxp3 transcription factors in an asthmatic mouse model.
    Kim SH; Hong JH; Lee JE; Lee YC
    Environ Toxicol Pharmacol; 2017 Jun; 52():99-113. PubMed ID: 28410469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent changes in the drug treatment of allergic asthma.
    Gibeon D; Menzies-Gow A
    Clin Med (Lond); 2013 Oct; 13(5):477-81. PubMed ID: 24115705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New insights into the treatment of severe asthma in children.
    Giovannini-Chami L; Albertini M; Scheinmann P; de Blic J
    Paediatr Respir Rev; 2015 Jun; 16(3):167-73. PubMed ID: 25182669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New drugs for asthma.
    Barnes PJ
    Nat Rev Drug Discov; 2004 Oct; 3(10):831-44. PubMed ID: 15459674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New therapies for asthma: is there any progress?
    Barnes PJ
    Trends Pharmacol Sci; 2010 Jul; 31(7):335-43. PubMed ID: 20554041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of biologics targeting type 2 airway inflammation in asthma: what have we learned so far?
    Parulekar AD; Diamant Z; Hanania NA
    Curr Opin Pulm Med; 2017 Jan; 23(1):3-11. PubMed ID: 27820746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibody therapy for the treatment of asthma and chronic obstructive pulmonary disease with eosinophilic inflammation.
    Nixon J; Newbold P; Mustelin T; Anderson GP; Kolbeck R
    Pharmacol Ther; 2017 Jan; 169():57-77. PubMed ID: 27773786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From phenotypes to endotypes to asthma treatment.
    Agache IO
    Curr Opin Allergy Clin Immunol; 2013 Jun; 13(3):249-56. PubMed ID: 23587683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.